Study for anti-GBM disease patients
Part of Immune system & allergy, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at people with anti-GBM disease, a rare kidney condition, to learn more about the disease and its treatment. If you were diagnosed between 2010 and 2027, or have stored blood or urine samples from your diagnosis, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with anti-GBM disease (a rare kidney condition where your immune system attacks your kidneys).
- For one part of the study, your diagnosis must have happened between January 1, 2010, and December 31, 2027.
- For another part, you must have stored blood or urine samples from the time you were diagnosed.
- For that part, your doctor must also know whether you were alive six months after your diagnosis.
- If you were diagnosed between 2010 and 2027, your doctor must have records of your first treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called SGB-9768 for people with certain kidney diseases that involve complement protein deposits. The goal is to see if it can reduce kidney damage and protein loss in urine.
This study tracks the long-term health of people with C3 glomerulopathy or IC-MPGN, two rare kidney diseases. It does not test a new treatment, but instead collects information from medical records to better understand how these conditions progress over time.
This trial looks at people with glioblastoma (GBM), a fast-growing brain tumor, to better understand it and how treatments might work. You may be able to join if you’re in a good general health range and have not had prior cancer chemotherapy.
This study looks for certain gene changes (GBA/PSAP) in people with multiple myeloma or MGUS. It aims to understand if these genes are linked to the disease, which may help guide future treatments.
This study looks at immune “B cells” in people with membranous nephropathy (a kidney disease). It includes people who have received or are being considered for B-cell–depleting treatment, aiming to better understand what drives the disease and how it may respond.
This study is looking for ways to find new drugs that may help people with Parkinson’s caused by changes in the GBA gene. It may also include people with Gaucher disease and healthy volunteers, using blood and possibly skin samples.
Hear when a new Anti-Glomerular Basement Membrane Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.